Michael P. Rettig

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia”.

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Blood(2020)10.1182/blood.2020007732

N/A

4.0DataRank · unranked

322 citations

Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani +43 more

Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies

Blood(2025)10.1182/blood.2025028387

N/A

0.531DataRank · unranked

19 citations

Ibrahim Aldoss, Shannon L. Maude, Deepa Bhojwani, Alan S. Wayne, Ashish Bajel +28 more

Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

European Journal of Nuclear Medicine and Molecular Imaging(2020)10.1007/s00259-020-05097-y

N/A

0DataRank · unranked

19 citations

Alexander Zheleznyak, Matt Mixdorf, Julie O’Neal, Julie Ritchey, Michael P. Rettig +4 more

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient

Blood Advances(2020)10.1182/bloodadvances.2019000664

N/A

0DataRank · unranked

14 citations

Michael P. Rettig, Phil Powell, Kathryn O’Brien, David B. Clifford, Julie Ritchey +9 more

VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2839

N/A

0DataRank · unranked

27 citations

Michael J. Scott, John S. Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan +12 more

Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome

Nature Communications(2021)10.1038/s41467-021-24800-7

N/A

0DataRank · unranked

49 citations

Taylor A. LaValle, Marwan Shinawi, Sai Mukund Ramakrishnan, Haley Abel, Cheryl A. Hill +14 more

Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors

Blood Advances(2021)10.1182/bloodadvances.2021005149

N/A

0DataRank · unranked

32 citations

Min Shi, Mark A. Fiala, Feng Gao, Michael P. Rettig, Geoffrey L. Uy +6 more

Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation

Journal of Clinical Investigation(2021)10.1172/jci145501

N/A

0DataRank · unranked

29 citations

Julie Ritchey, Sena Kim, Sora Lim, Peter Ruminski, Matthew Cooper +4 more

A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1872068

N/A

0DataRank · unranked

8 citations

Michael P. Rettig, Theresa Fletcher, Julie Ritchey, Leah Gehrs, Kyle McFarland +15 more

Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.12.426397

N/A

0DataRank · unranked

4 citations

Carla Valenzuela Ripoll, Antonino Picataggi, David R. Rawnsley, Mualla Özcan, Julio A. Chirinos +29 more

A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity

Nature Communications(2022)10.1038/s41467-022-30860-0

N/A

0DataRank · unranked

97 citations

Reyka G. Jayasinghe, Jessica M. Devenport, Julie Ritchey, Michael P. Rettig, Julie O’Neal +8 more

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

Leukemia(2022)10.1038/s41375-022-01559-4

N/A

0DataRank · unranked

55 citations

Julie Ritchey, Matthew Cooper, Jessica Niswonger, Luisalberto Gonzalez, Emily Street +12 more

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

Scientific Reports(2022)10.1038/s41598-021-03748-0

N/A

0DataRank · unranked

23 citations

Chantiya Chanswangphuwana, Nicholas S. Cho, Francesca Fontana, Dolonchampa Maji, Julie Ritchey +10 more

Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma

Leukemia(2022)10.1038/s41375-022-01691-1

N/A

0DataRank · unranked

15 citations

Thomas G. Martin, Nitya Nathwani, Mark A. Fiala, Michael P. Rettig, Feng Gao +10 more

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial

Nature Medicine(2023)10.1038/s41591-023-02273-z

N/A

0DataRank · unranked

76 citations

Michael P. Rettig, Reyka G. Jayasinghe, Keith Stockerl‐Goldstein, Sarah Larson, Illes Arpad +27 more

An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies

Leukemia(2023)10.1038/s41375-023-02039-z

N/A

0DataRank · unranked

39 citations

Jessica M. Devenport, Alun Carter, Karl Staser, Miriam Kim, Julie O’ Neal +9 more

Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury

JACC Basic to Translational Science(2023)10.1016/j.jacbts.2022.09.010

N/A

0DataRank · unranked

35 citations

Carla Valenzuela Ripoll, Antonino Picataggi, David R. Rawnsley, Mualla Özcan, Julio A. Chirinos +29 more

Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells

Biomolecules(2024)10.3390/biom14081003

N/A

0DataRank · unranked

15 citations

Michael P. Rettig, John F. Dipersio, Peter Ruminski

Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization

Blood Advances(2024)10.1182/bloodadvances.2023011653

N/A

0DataRank · unranked

15 citations

Michael P. Rettig, Darja Karpova, Haresh Thakellapalli, Megh Singh, Marvin J. Meyers +9 more

A simplified G-CSF–free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model

Blood Advances(2024)10.1182/bloodadvances.2024012757

N/A

0DataRank · unranked

12 citations

Anna Kate Anderson, Peter Ruminski, Michael P. Rettig, Darja Karpova, Hans‐Peter Kiem +3 more

Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager

PLoS ONE(2024)10.1371/journal.pone.0300174

N/A

0DataRank · unranked

5 citations

Julie Ritchey, Michael P. Rettig, Dilan A. Patel, Kiran Vij, Feng Gao +4 more

Streptavidin-drug conjugates streamline optimization of antibody-based conditioning for hematopoietic stem cell transplantation

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.12.579199

N/A

0DataRank · unranked

2 citations

Ezhilarasi Chendamarai, Julie Ritchey, Michael P. Rettig, John F. Dipersio, Stephen P. Persaud +1 more

JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow Transplantation

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.03.672211

N/A

0DataRank · unranked

0 citations

Hassan Bjeije, Hamza Celik, Michael P. Rettig, Nancy Issa, Andrew L. Young +11 more

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Blood Advances(2020)10.1182/bloodadvances.2020002512

N/A

0DataRank · unranked

154 citations

Catherine Lai, Stephen Reeder, S. Church, Tressa Hood, Anbarasu Lourdusamy +24 more

Streptavidin-drug conjugates streamline optimization of antibody-based hematopoietic stem cell transplant conditioning

Blood Immunology & Cellular Therapy(2025)10.1016/j.bict.2025.100012

N/A

0DataRank · unranked

0 citations

Ezhilarasi Chendamarai, Julie Ritchey, Michael P. Rettig, John F. Dipersio, Stephen P. Persaud +1 more

Targeting CXCR4 in AML and ALL

Frontiers in Oncology(2020)10.3389/fonc.2020.01672

N/A

0DataRank · unranked

108 citations

Michael P. Rettig, John F. Dipersio, Daniel Cancilla